New Technologies to Help Manage ADHD



Status:Active, not recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:6 - 10
Updated:3/25/2017
Start Date:September 2015
End Date:March 2018

Use our guide to learn which trials are right for you!

Developing New Technologies to Improve ADHD Medication Continuity

Cluster randomized controlled trial to evaluate the general effectiveness of intervention
compared to control on medication continuity as measured by prescriptions written and other
more proximal outcomes during the first six months of treatment.

This cluster randomized controlled trial will evaluate the general effectiveness of the
intervention (e.g. enhanced myADHDportal.com), compared to control (e.g. treatment as usual
standard portal), on medication continuity as measured by prescriptions written and other
more proximal outcomes during the first six months of treatment.

Inclusion Criteria:

- Parents of children are eligible to participate if

1. their child receives ADHD care at one of the pediatric primary care practices
that is partnering to conduct this trial

2. child being registered on myADHDportal.com to initiate child assessment of ADHD

3. child age 6-10 years

4. child must not have been previously treated with ADHD medication

5. child prescribed ADHD medication within 12 months of enrolling in the study

Exclusion Criteria:

- Unable to read and speak English
We found this trial at
1
site
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Principal Investigator: William Brinkman, MD, MEd, MSc
Phone: 513-803-1931
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials